SENS Jan 2024 3.000 call
| Previous close | 0.0500 |
| Open | 0.0500 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 3.00 |
| Expiry date | 2024-01-19 |
| Day's range | 0.0500 - 0.0500 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
Business WireSenseonics Announces the Last Patient Completion of the 365-Day ENHANCE Pivotal Clinical Study
GERMANTOWN, Md., September 26, 2023--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced the completion of the ENHANCE Pivotal Clinical Study adult cohort following the recently completed 365-day visit for the final study patient.
Business WireSenseonics Holdings, Inc. to Participate in the Gilmartin Group Emerging Growth Company Showcase
GERMANTOWN, Md., September 14, 2023--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Gilmartin Group Emerging Growth Company Showcase, taking place virtually.
Business WireSenseonics Holdings, Inc. Enters Into $50 Million Loan Facility With Hercules Capital
GERMANTOWN, Md., September 11, 2023--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it has entered into a $50 million loan facility with Hercules Capital, Inc. (NYSE: HTGC) ("Hercules"). The company also announced it drew down $25 million upon the transaction closing.
